APPLICATIONS PUBLISHED 18 OCTOBER 2006

Published: 5-Mar-2007


Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH
Durect 1711160*

Methods for preventing and treating SARS using low Ph respiratory tract compsns
Procter & Gamble 1711161*

Method for the diffusion of molecules which are insoluble in an aqueous medium and compsn using said method
Perovitch, Phillippe, Maury, Marc 1711162*

Dispersions prepared by use of self-stabilised agents
Baxter International 1711163*

Method of treating acute rhinosinusitis
Schering 1711164*

Membrane scaffold proteins
The Board of Trustees of the University of Illinois 1711165*

Stable amorphous forms of montelukast sodium
Chemagis 1711166*

Multiparticulate O-desmethylvenlafaxine salts and uses thereof
Wyeth 1711167*

Oral pharmaceutical compsns of candesartan cilexetil
Ranbaxy Laboratories 1711168*

Extended release coated microtablets of venlafaxine hydrochloride
Alembic 1711169*

Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid
Lavipharm Laboratories 1711170*

Vitamin E for facilitating the synchronisation of circadian rhythm
DSM IP Assets 1711171*

Compsns and methods for combined therapy of disease
The Trustees of the University of Pennsylvania 1711173*

Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or ester thereof
Igennus 1711173*

Adjuvant compsns
MNL Pharma 1711174*

Diurea derivatives
Active Biotech 1711175*

Immunomodulatory alkaloids
MNL Pharma 1711176*

1H-thieno 2,3-c pyrazole derivatives useful as kinase inhibitors
Pfizer Italia 1711177*

Compsns substantially free of galactomannan containing piperacillin and tazobactam
Wyeth 1711178*

Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (S)-pantoprazole
Altana Pharma 1711179*

Thiazolyimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein
Merck Patent 1711180*

Quinoline derivatives and use thereof as mycobacterial inhibitors
Janssen Pharmaceutica 1711181*

Oral cyclodextrin complexes of anti-tuberculosis drugs
Sapte, Vinay Ramakant 1711182*

Muscarinic acetylcholine receptor antagonists
Glaxo Grouo 1711183*

(3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
Janssen Pharmaceutica 1711184*

Combination of CDK inhibitor and CS-682 or a metabolite thereof
Cyclacel 1711185*

Slow release steroid compsn
RetMed Pty 1711186*

Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation
Advisys 1711187*

Anticancer therapies
Threshold Pharmaceuticals 1711188*

6,11,3C-bicyclic 8A-azalide derivatives
Merck 1711189*

You may also like